etoposide has been researched along with Cognition Disorders in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartels, U; Bouffet, E; Greenberg, M; Halliday, W; Kamaly-Asl, ID; Kulkarni, AV; Lafay-Cousin, L; Mabbott, DJ; Tabori, U; Taylor, MD | 1 |
Fujii, M; Ito, M; Momota, H; Motomura, K; Natsume, A; Wakabayashi, T | 1 |
Kamani, N; Lafond, D; Loechelt, B; MacDonald, TJ; Packer, RJ; Perez-Albuerne, E; Rood, B; Thorarinsdottir, HK | 1 |
Boogerd, W; Huinink, WT; Meinhardt, W; Moonen, L; Muller, MJ; Schagen, SB; Van Dam, FS | 1 |
Allen, PK; Davenport, SD; Grosshans, DR; Komaki, R; Meyers, CA | 1 |
Crowell, EB; Higa, GM; Wise, TC | 1 |
Alvarnas, JC; Blume, KG; Chao, NJ; Horning, SJ; Hu, WW; Long, GD; Negrin, RS; Schriber, JR; Stockerl-Goldstein, K; Tierney, K; Wong, R | 1 |
1 trial(s) available for etoposide and Cognition Disorders
Article | Year |
---|---|
Neurocognitive function in patients with small cell lung cancer : effect of prophylactic cranial irradiation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cognition; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Radiation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Psychomotor Performance; Speech | 2008 |
6 other study(ies) available for etoposide and Cognition Disorders
Article | Year |
---|---|
Use of ifosfamide, carboplatin, and etoposide chemotherapy in choroid plexus carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Damage, Chronic; Carboplatin; Child, Preschool; Choroid Plexus Neoplasms; Cognition Disorders; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Neoadjuvant Therapy; Postoperative Complications; Reoperation; Retrospective Studies | 2010 |
Long-term survival in patients with newly diagnosed primary central nervous system lymphoma treated with dexamethasone, etoposide, ifosfamide and carboplatin chemotherapy and whole-brain radiation therapy.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Chemoradiotherapy; Cognition Disorders; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Lymphoma; Male; Middle Aged; Outcome Assessment, Health Care; Radiotherapy; Retrospective Studies; Survivors; Young Adult | 2011 |
Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cognition Disorders; Cranial Irradiation; Cyclophosphamide; Developmental Disabilities; Disease-Free Survival; Ependymoma; Etoposide; Follow-Up Studies; Ganglioglioma; Glioma; Humans; Infant; Medulloblastoma; Mitotic Index; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Peripheral Blood Stem Cell Transplantation; Quadriplegia; Retrospective Studies; Sensation Disorders; Spinal Cord Neoplasms; Thiotepa; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cognition; Cognition Disorders; Etoposide; Fatigue; Humans; Male; Neuropsychological Tests; Risk Assessment; Risk Factors; Stress, Psychological; Surveys and Questionnaires; Testicular Neoplasms; Time Factors | 2008 |
Severe, disabling neurologic toxicity following cisplatin retreatment.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Cerebrovascular Disorders; Cisplatin; Cognition Disorders; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms | 1995 |
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelitis, Transverse; Neoplasm Invasiveness; Quality of Life; Radiation Injuries; Survival Analysis; Survival Rate; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2000 |